[go: up one dir, main page]

AR109263A2 - Composición que comprende moxidectina - Google Patents

Composición que comprende moxidectina

Info

Publication number
AR109263A2
AR109263A2 ARP170101975A ARP170101975A AR109263A2 AR 109263 A2 AR109263 A2 AR 109263A2 AR P170101975 A ARP170101975 A AR P170101975A AR P170101975 A ARP170101975 A AR P170101975A AR 109263 A2 AR109263 A2 AR 109263A2
Authority
AR
Argentina
Prior art keywords
moxidectine
composition including
composition
demodicosis
moxidectin
Prior art date
Application number
ARP170101975A
Other languages
English (en)
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35614662&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR109263(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of AR109263A2 publication Critical patent/AR109263A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Reivindicación 1: Una composición que comprende moxidectina, caracterizada porque se usa en la preparación de un medicamento de aplicación externa para el tratamiento de la demodicosis. Reivindicación 2: Una composición de acuerdo con la reivindicación 1, caracterizada porque además comprende imidacloprid.
ARP170101975A 2004-11-09 2017-07-14 Composición que comprende moxidectina AR109263A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004053964A DE102004053964A1 (de) 2004-11-09 2004-11-09 Mittel gegen Demodikose

Publications (1)

Publication Number Publication Date
AR109263A2 true AR109263A2 (es) 2018-11-14

Family

ID=35614662

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP050104675A AR051664A1 (es) 2004-11-09 2005-11-08 Agente contra la demodicosis
ARP170101975A AR109263A2 (es) 2004-11-09 2017-07-14 Composición que comprende moxidectina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP050104675A AR051664A1 (es) 2004-11-09 2005-11-08 Agente contra la demodicosis

Country Status (16)

Country Link
US (1) US9662309B2 (es)
EP (1) EP1811990B1 (es)
AR (2) AR051664A1 (es)
AU (1) AU2005304103B2 (es)
BR (2) BR122019002159B1 (es)
DE (1) DE102004053964A1 (es)
DK (1) DK1811990T3 (es)
ES (1) ES2711329T3 (es)
HU (1) HUE041365T2 (es)
LT (1) LT1811990T (es)
PL (1) PL1811990T3 (es)
PT (1) PT1811990T (es)
SI (1) SI1811990T1 (es)
TR (1) TR201901390T4 (es)
TW (1) TWI432205B (es)
WO (1) WO2006050816A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2947453B1 (fr) * 2009-07-03 2011-08-19 Akil Sa Medicament antiparasitaire pour application topique contre les affections dues au demodex
CN103641873B (zh) * 2013-12-17 2015-10-28 华北制药集团爱诺有限公司 一种阿维菌素的制备方法
WO2016022066A1 (en) 2014-08-04 2016-02-11 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
PL3236960T3 (pl) * 2014-12-22 2025-07-07 Intervet International B.V. Fluralaner do zastosowania w leczeniu demodekozy
RU2568869C1 (ru) * 2015-01-16 2015-11-20 Федеральное государственное бюджетное научное учреждение Всероссийский научно-исследовательский институт фундаментальной и прикладной паразитологии животных и растений им. К.И. Скрябина (ФГБНУ "ВНИИП им. К.И. Скрябина") Способ лечения демодекоза собак
RU2634265C1 (ru) * 2016-10-18 2017-10-24 Федеральное государственное бюджетное учреждение науки Федеральный исследовательский центр Тюменский научный центр Сибирского отделения Российской академии наук (ТюмНЦ СО РАН) Способ лечения демодекоза собак
KR20250065422A (ko) 2017-12-15 2025-05-12 타르서스 파마수티칼스, 아이엔씨. 안검염을 치료하기 위한 이속사졸린 구충제 제제 및 방법
CN113557015A (zh) * 2018-12-21 2021-10-26 礼蓝美国公司 杀寄生虫制剂及其用途
WO2020150032A1 (en) * 2019-01-16 2020-07-23 Boehringer Ingelheim Animal Health USA Inc. Topical compositions comprising a neonicotinoid and a macrocyclic lactone, methods and uses thereof
SI3815677T1 (sl) 2019-10-30 2023-12-29 Krka, D.D., Novo Mesto Stabilni veterinarski sestavek, ki obsega moksidektin in imidakloprid
WO2023111333A1 (en) * 2021-12-17 2023-06-22 Bayer Animal Health Gmbh Topical administration of composition comprising 10% w/v imidacloprid and 1% w/v moxidectin for the treatment of troglostrongylosis in cats

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426333B1 (en) * 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
JPS4914624A (es) 1972-06-08 1974-02-08
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
DE3727648A1 (de) * 1987-08-19 1989-03-02 Bayer Ag Neue avermectin derivate, verfahren zu ihrer herstellung und ihre verwendung
NZ233680A (en) * 1989-05-17 1995-02-24 Beecham Group Plc Avermectins and milbemycins and compositions thereof
ATE130006T1 (de) 1989-09-11 1995-11-15 American Cyanamid Co 13-alkyl-23-imino und 13-halo-23-imino-derivate von ll-f28249-verbindungen und ihre verwendung als endo- und ectoparasitizide, insektizide, akarizide und nematozide mittel.
GB9024927D0 (en) * 1990-11-16 1991-01-02 Beecham Group Plc Novel treatment
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19654079A1 (de) * 1996-12-23 1998-06-25 Bayer Ag Endo-ekto-parasitizide Mittel
US5952372A (en) * 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
PE20011289A1 (es) * 2000-04-07 2001-12-21 Upjohn Co Composiciones antihelminticas que comprenden lactonas macrociclicas y espirodioxepinoindoles
DE10117676A1 (de) * 2001-04-09 2002-10-10 Bayer Ag Dermal applizierbare flüssige Formulierungen zur Bekämpfung von parasitierenden Insekten an Tieren
DK1610613T3 (en) * 2003-04-04 2017-02-27 Merial Inc TOPICAL ANTHELMINTIC VETERINARY FORMULATIONS
US7514464B2 (en) * 2003-12-18 2009-04-07 Pfizer Limited Substituted arylpyrazoles

Also Published As

Publication number Publication date
US20080039519A1 (en) 2008-02-14
TW200626162A (en) 2006-08-01
TR201901390T4 (tr) 2019-02-21
AU2005304103A1 (en) 2006-05-18
US9662309B2 (en) 2017-05-30
HUE041365T2 (hu) 2019-05-28
LT1811990T (lt) 2019-02-25
BRPI0517966A (pt) 2008-10-28
BR122019002159B1 (pt) 2021-08-17
EP1811990B1 (de) 2018-11-21
AU2005304103B2 (en) 2012-02-02
PT1811990T (pt) 2019-02-19
SI1811990T1 (sl) 2019-03-29
TWI432205B (zh) 2014-04-01
AR051664A1 (es) 2007-01-31
BRPI0517966B1 (pt) 2023-09-26
ES2711329T3 (es) 2019-05-03
DK1811990T3 (en) 2019-03-11
PL1811990T3 (pl) 2019-05-31
EP1811990A1 (de) 2007-08-01
DE102004053964A1 (de) 2006-05-11
WO2006050816A1 (de) 2006-05-18

Similar Documents

Publication Publication Date Title
AR109263A2 (es) Composición que comprende moxidectina
CR7583A (es) Nueva sal formiato de o-desmetil venlafaxina
ECSP077296A (es) Fenilaminotiazoles sustituidos y su uso
NI200800169A (es) Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento del dolor
CR7140A (es) Antranilamidas con una cadena colateral de un heteroarylsulfonil, metodos para la produccion de los mismos, su uso como medicamento o agente diagnostico y preparaciones farmaceuticas contenidas en dichos compuestos
CL2007003643A1 (es) Composicion farmaceutica de azimilidina que comprende 0,5% a aproximadamente 2,5% (w/w) de agua; y uso para el tratamiento de arritmias cardiacas.
AR032872A1 (es) Composicion para aclarar la piel y el metodo de aplicacion
PE20060594A1 (es) Composicion farmaceutica que contiene un agonista de ppar
CL2008003231A1 (es) Compuestos derivados de 1,3-dihidro-5-isobenzofurancarbonitrilo sustituido, inhibidores selectivos de la recaptacion de serotonina; composicion farmaceutica; procedimiento de preparacion; utiles en el tratamiento y/o prevencion de la eyaculacion prematura.
UY28154A1 (es) Composiciones y metodos de cuidado oral
PA8571901A1 (es) Nueva composicion farmaceutica
DK1414467T3 (da) Topisk behandling af mastalgi
ECSP10010464A (es) Uso de ranolazina para el tratamiento de enfermedades cardiovasculares
AR056500A1 (es) Metodo para preparar una composicion medica
AR046402A1 (es) Combinacion de principio activo que comprende un compuesto 2,5-dihidrobencenosulfonico y un modulador de los canales de potasio
UY29445A1 (es) Composiciones para la transmisión transmucosa oral de la metformina
CL2008002223A1 (es) Compuestos derivados de 9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a 2'-o-sustituida; proceso de preparación; compuesto intermediario; composición farmacéutica; y su uso en el tratamiento y/o profilaxis de la malaria.
ES2325291A1 (es) "uso de un extracto de silybum marianum"
SE0000303D0 (sv) Novel compounds
PA8651401A1 (es) Formas de dosificacion oral solidas que contienen una dosis baja de estradiol
CL2007001794A1 (es) Compuestos derivados de 2-imidazolidinona, inhibidores del canal de potasio kv1.5; composicion farmaceutica que los comprende; y su uso para tratar o prevenir arritmias cardiacas. tromboembolia,apoplejia,insuficiencia cardiaca.
PA8558501A1 (es) 1,3-diarilprop-2-en1-onas, composiciones que las contienen y su utilizacion
AR030660A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso de la produccion de il-12
BRPI0510906A (pt) composição farmacêutica tópica, composição para administração tópica e seu uso
CL2004000633A1 (es) Compuestos copolimeros, composicion farmaceutica que los contiene y procedimiento de preparacion, utiles en el tratamiento de enfermedades metabolicas oseas.

Legal Events

Date Code Title Description
FC Refusal